XML 26 R13.htm IDEA: XBRL DOCUMENT v3.25.1
Related Party Transactions
 3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 7 – RELATED PARTY TRANSACTIONS

 

UCL

 

At March 31, 2025 and December 31, 2024, the Company recorded a payable to UCL of $52,000 and $0, respectively, for medical research performed on behalf of the Company. During the three months ended March 31, 2025 and 2024, the Company made no payments to UCL. UCL is a wholly owned subsidiary of the University of London. The Company’s Chief Scientific and Manufacturing Officer is a professor at the University of London.

 

AmplifyBio

 

At March 31, 2025 and December 31, 2024, the Company recorded a payable to AmplifyBio of $26,000 and $0, respectively, for medical research performed on behalf of the Company. During the three months ended March 31, 2025 and 2024, the Company paid AmplifyBio $41,000 and $142,000, respectively. The CEO of AmplifyBio is on the Board of Directors of the Company.